1:2:1 Podcast : Aging
Christopher Scott on the new face of longevity research
Stanford bioethicist Christopher Scott, PhD, says longevity research is on the brink of something big.
Mehrdad Ayati on the "Paths to Healthy Aging"
Stanford geriatrician Mehrdad Ayati, MD, calls his new book Paths to Healthy Aging a simple workbook and is aimed at the accessible reader who wants basic information about aging. Co-written with his wife, Hope Azarani, PhD, the book is about creating a lifestyle that will lead readers towards the path of a happy and healthy aging process.
VJ Periyakoil on doctors and end-of-life directives
A new study by VJ Periyakoil, MD, director of palliative care education and training at the Stanford School of Medicine, examined physicians' attitudes toward advance directives and found little has changed since the law's passage in 1990, with most saying they would continue to pursue aggressive treatment for terminally ill patients. In this podcast, Periyakoil discusses why doctors want one thing for themselves at the end of life and quite another for their patients.
Boosting life expectancy with foreign aid
Many argue that international health aid is wasted and doesn't reach the people who really need it. But a new Stanford analysis of both government and private aid programs shows that the funding leads to significant improvements, especially in life expectancy and child mortality rates. In this podcast, health-policy expert Eran Bendavid, MD, discusses the new study.
Ellen Goodman on 'the conversation'
After her mother’s death, Ellen Goodman, the Pulitzer-prize winning columnist for the Boston Globe and author was reminded of the importance of having “the conversation.” She launched “The Conversation Project,” a national movement dedicated to the wishes of end-of-life care. In this podcast, she talks about the project, what she hopes to accomplish through the initiative and why she believes having the conversation is probably the most important discussion you’ll ever have.
Accelerated aging in women
A new study has found that for healthy women carrying a well-known genetic risk factor for Alzheimer's disease, estrogen therapy that could be beneficial. Women with the risk factor exhibited signs of accelerated biological aging. However, among at-risk women who used estrogen, the acceleration was absent. In this podcast, Natalie Rasgon, MD, PhD, director of the Stanford Center for Neuroscience in Women’s Health and a senior author of the study, discusses the findings and how the research may help determine the types of women who might benefit from hormone therapy.
Walter Bortz discusses the science and civics of health
One look at Walter Bortz, MD, and there is no denying that he practices what he preaches.
Laura Carstensen on aging
In her new book, A Long Bright Future, Laura Carstensen, PhD, director of the Stanford Center on Longevity, writes that life is getting longer for most of the people on our planet.